Association between overt, subclinical hypothyroidism and metabolic dysfunction-associated steatotic liver disease using magnetic resonance imaging

Figure 1 Magnetic resonance imaging of one of our patients exhibiting mild steatosis. A-C: Magnetic resonance imaging scan of a female patient, demonstrate axial in-phase; D-F: Out-of-phase sequences showing region of interest, calculated hepatic fat percentage (6.8%) and fepatic fat fraction (10.5%) matching with mild steatosis.

Figure 2 Magnetic resonance imaging of one of our patients exhibiting moderate steatosis. A-C: Magnetic resonance imaging scan of a female patient, demonstrate axial in-phase; D-F: Out-of-phase sequences showing applied region of interest (ROI’s), calculated hepatic fat percentage (32.2%) and hepatic fat fraction (33%), matching with moderate steatosis.

Figure 3 Receiver operating characteristic curve for thyroid stimulating hormone and risk of metabolic dysfunction-associated steatotic liver disease development.